Pazoci 200 Tablet
Marketer
Cipla Ltd
Salt Composition
Pazopanib (200mg)
Overview Pazoci 200 Tablet
Sorafenib 200mg tablets are a tyrosine kinase inhibitor indicated for kidney and soft tissue sarcoma. Dosage should strictly adhere to your physician's prescription, continuing treatment for the duration they specify. Treatment length depends on individual response. Regular blood pressure monitoring may be recommended due to the potential for hypertension. Effective contraception is crucial for women during treatment and for a month post-treatment to prevent pregnancy. Diarrhea is a possible side effect; increased fluid intake is advised, but persistent diarrhea requires medical attention. Weight loss may occur; consult a nutritionist or adjust food intake accordingly. Hair discoloration and skin pigmentation changes are also possible; consult your doctor if these are bothersome. A patient assistance program, facilitated by Tata 1mg, exists in India. Contact your doctor or call (1800-102-1618) for program details.
Uses of Pazoci 200 Tablet
Renal cell carcinoma or soft tissue sarcoma.
Major Benefits of Pazoci 200 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pazoci 200 Tablet whole; do not crush, chew, or divide it. Administer on an empty stomach.
Common Side effects of Pazoci 200 Tablet:
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Pazoci 200 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pazoci 200 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Pazoci 200 Tablet works:
Pazoci 200 Tablet combats cancer by targeting and blocking tyrosine kinase enzyme receptors crucial for tumor cell multiplication. This action also restricts the development of new blood vessels supplying the cancerous growth, thus impeding its progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pazoci 200 Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Pazoci 200 Tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Pazoci 200 Tablet are incompatible; the medication poses a potential risk of infant toxicity.
DrivingUNSAFE
Taking Pazoci 200 Tablet may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Pazoci 200 Tablets can be used safely by individuals with kidney impairment; no dosage alteration is necessary.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Pazoci 200 Tablets, as dose modification may be necessary. Consult a physician before use. Pazoci 200 Tablets are contraindicated for patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Pazoci 200 Tablet :
NA
Facts to Know About Pazoci 200 Tablet
| Label | Value |
|---|---|
| Chemical Category | Diarylalkaneamines |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Active Class | Kinase inhibitors targeting tyrosine |

